Global Biotherapeutics Cell Line Development Market to reach US$99.8 mn by 2022, Propelled by Rising Demand for Monoclonal Antibodies Transparency Market Research has published a new report on the global biotherapeutics cell line development market. As per the report, the global biotherapeutics cell line development market is expected to expand at a 7.50% CAGR from 2015 to 2022. The report, titled ‘Biotherapeutics Cell Line Development Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2022,’ states that the global biotherapeutics cell line development market is expected to progress from US$56 mn in 2014 to US$99.8 mn by 2022 owing to factors such as the rising demand for monoclonal antibodies and the rising initiatives taken by the governments of various nations to fund life sciences research and development. The biotherapeutics industry continues to grow swiftly owing to the growing demand for mammalian cell line development. Over the past few years, big pharmaceutical companies have been pursuing the development of small molecule drugs by aggressively investing in biotechnology. The increasing
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.